Immuno-oncology and Drug Discovery

Jul 17-18, 2019

Dubai, United Arab Emirates

Immuno-oncology and Drug Discovery

LEXIS welcomes you all to its first Immuno-oncology & Drug Discovery conference which will take place in Dubai, UAE during July 17-18, 2019.  Through a unique platform, this conference plans to draw in numerous world renowned scientists, oncologists, surgical oncologists, practitioners, health care providers, immunologists, dermatologists, CRO’s, industry leaders and other experts who actively engage in Immunotherapy.

Our main objective by organizing this conference is to provide state of art information on tumor biology, cancer epidemiology, cancer immunology and immunotherapy for various types of cancer, treatment, prevention and risks associated, to an international audience of researchers, academicians and private physicians.

Immuno-oncology & Drug Discovery 2019 (IMDD 2019) conference will also provide an excellent international forum for sharing latest knowledge in immunotherapies and interpretation of new data which result in increasing awareness among the population thus driving a huge growth for the need of drug discovery for Cancer. Through it’s thought provoking discussions and networking among the stakeholders and scientists, this conference will succeed in building long lasting collaborations with an international mix of delegates and scientists both from industry and academia.

Target Audiences:-

1. Immunologists

2. Oncologists

3. Clinical Oncologists

4. Directors, Scientists and Researchers from Academia and Industries

5. Industry Experts involved in Immuno-oncology

6. Pharma and Biotech companies

7. Doctors and Physicians

8. Surgeons

9. Registered Nurses, Nurse Practitioners, Pharmacists, Emergency Physicians and the entire cancer care team

10. Residents, Fellow, Students and Survivors


The global cancer immunotherapy market according to a latest report is expected to grow with a CAGR of 14.5% over the period of 2018-2024 from an estimated value of US$ 43,085.5 million in 2016.

There are several key factors that drive the growth of immunotherapy market which includes increase in R&D for cancer treatment due to rise and prevalence of cancer, technological advancements in treatment therapies and specificity & effectiveness of cancer immunotherapy for the treatment of various types of cancers like breast cancer, lung cancer, skin cancer and others.

As per geographic segmentation, North America holds the largest market share in terms of revenue in 2016 followed by Europe. Asia Pacific on the other hand is expected to experience fastest growth due to rising mortality rate is pushing the demand for immunotherapy. Latin America, Middle East and Africa (LAMEA) cancer immunotherapy market size has been registered a growth rate of 17.9% CAGR during the forecast period (2017-2023) which is due to growing patient population that are suffering from various cancer types and additionally growing geriatric population and governmental contribution to healthcare expenditure are some of the driving factors for market growth.


Abstract Submission Opens: 1st November 2018

Early Bird Registration Opens: 9th November 2018

Early Bird Ends On: 30th November 2018

Note: The Proceeding will be archived in Digital Library. Each Paper will be assigned Digital Object Identifier (DOI) from CROSSREF. The Proceedings will be published in International Journals of lexis.

We welcome paper submissions. Prospective authors are invited to submit full research papers (which are NOT submitted/published/under consideration anywhere in other conferences/journal) in (doc only) format.

Details of Immuno-oncology and Drug Discovery 2019:

Conference Name Place Date
Immuno-oncology and Drug Discovery Conference 2019 Dubai, UAE July 17-18, 2019